1 of 14

Narcolepsy

Approximation to diagnostic: multiple sleep latency test (MSLT)

Ovidiu C. Banea

�Clinical Neurophysiology Unit

Reykjavík, 09th of December 2016

2 of 14

Reason

Motor control and emotions

SUMMARY

Basic Knowledge - video open source

Excessive Daytime Sleepiness Scale

Major CNS Hypersomnia Types

International Classification of Sleep Disorder (ICSD - 3) and narcolepsy

Keys for diagnostic

Narcolepsy in Iceland - available internet literature

Sleep Onset REM period SOREMp and Multiple Sleep Latency Test (MSLT)

French Consensus

Conclusions

3 of 14

Basic

knowledge

1:2000

4 of 14

Epworth Scale

5 of 14

Comparison of Major CNS Hypersomnia Types

Narcolepsy w/Cataplexy

IH with long sleep time

IH without long sleep time

Recurrent Hypersomnia

(KLS, Menstrual)

Symptoms

EDS, SP, HH,

cataplexy, fragmented sleep

Nocturnal sleep time > 10h

Nocturnal sleep

> 6 h & < 10 h

Excessive sleepiness

last 2d – 4 weeks

Frequency

Almost daily for ≥3 months

Almost daily for ≥3 months

Almost daily for ≥3 months

Recurrence at least once per year

PSG findings

Short SL and

sleep > 10 hours

Short SL and

sleep > 10 hours

Sleep > 6 h < 10 h �

-

MSLT

Mean SL ≤ 8 min and

≥ 2 SOREMPs

Mean SL ≤ 8 min and

< 2 SOREMPs

Mean SL ≤ 8 min and

< 2 SOREMPs

-

6 of 14

Types

ICD-3

7 of 14

Keys: pentad (usually ⅗)

-Hypersomnia (Excesive Daytime Sleepiness), most common symptom

-Disrupted (disturbed) sleep (70-80%) sometimes periods of night wakefullness

-Cataplexy (approx 70%) usualy, appears after EDS, few years

-Hypnagogic or Hypnopompic visual, auditory or tactile hallucinations (20-40%)

-Sleep paralysis (25-50%)

8 of 14

Narcolepsy in Iceland

9 of 14

? SOREMP & MSLT

Neurophysiology lab

Icelandic language

2008

Protocol PSG

Protocol MSLT

10 of 14

French consensus 2016

New International classification of sleep disorders (ICSD-3) named 2 types

NT1: periods of an irrepressible need to sleep, cataplexy (a sudden loss of muscle tone triggered by emotion) and in some cases the presence of symptoms such as hypnagogic hallucinations, sleep paralysis and disturbed night-time sleep. Loss of hypocretin neurons in the hypothalamus, an auto-immune process.

NT2: cataplexy is absent and the hypocretin levels in the CSF are normal.

Confirming the diagnosis requires polysomnography and multiple sleep latency tests.

The choice of further investigations is based on the presence or absence of typical cataplexy. Further investigations include HLA typing, lumbar puncture to measure the hypocretin level in the CSF, or even brain imagery in the case of narcolepsy suspected to be secondary to an underlying pathology.

11 of 14

French consensus 2016

Monaca et al

2016

12 of 14

Conclusions

  • Narcolepsy is a long term neurological disorder that involves a decreased ability to regulate sleep-wake cycles
  • Two tests are essential in confirming a diagnosis of narcolepsy: the polysomnogram (PSG) and the multiple sleep latency test (MSLT) specially for Narcolepsy type 2
  • In Iceland the incidence of narcolepsy is not known and the disorder could be underestimated
  • MSLT should return and be performed in Neurology Department Landspítali

13 of 14

Takk fyrir

14 of 14

Additional